Role of ATP-Binding Cassette (ABC) Transporters in Interactions Between Natural Products and Drugs

被引:47
作者
Aszalos, Adorjan [1 ]
机构
[1] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
P-glycoprotein; multidrug resistance protein; breast cancer resistance protein; flavonoids; mycotoxins; food-drug interactions;
D O I
10.2174/138920008786927776
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Medicinal use of natural products such as extracts of plants has existed for many years in China and in other countries and they are now available worldwide. Citrus fruit juices are consumed on a daily basis around the world. Modern medicine provides well-tested compounds or drugs for most sicknesses. However, the simultaneous consumption of plant extracts, food supplements, and fruit juices with drugs can create metabolic aberrations in humans. Interactions between drugs used simultaneously are regulated by government agencies. Not regulated, but warned against in drug inserts are potential interactions between drugs and food and food-additives containing certain compounds with potential side effects. Summarized here are the results of investigations that point out possible interactions at the level of transporter molecules by drugs and compounds of natural origin. These transporter molecules play important roles in absorption in the intestines, at the blood brain barrier, in the liver, the kidney and in some other parts of the human body. Drugs and metabolites pass through these pumps and may compete with compounds from food supplements. The most studied natural compounds that are potential modulators of these transport molecules are flavonoids, found in fruit juices, vegetables, flowers and tea. Mycotoxins found in cereal grains are also shown to modulate transporter proteins. We detail here how such constituents of natural origin were shown to modulate three types of the major transporter molecules, P-glycoprotein (ABCB1), multidrug resistance proteins (ABCCs) and breast cancer resistance protein (ABCG2). Interference of these natural compounds with drugs at the transporter level is also discussed.
引用
收藏
页码:1010 / 1018
页数:9
相关论文
共 73 条
[1]  
Aszalos A, 2007, DRUG DISCOV TODAY, V12, P838, DOI 10.1016/j.drudis.2007.07.021
[2]   Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice [J].
Bailey, D. G. ;
Dresser, G. K. ;
Leake, B. F. ;
Kim, R. B. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (04) :495-502
[3]   GRAPEFRUIT JUICE FELODIPINE INTERACTION - MECHANISM, PREDICTABILITY, AND EFFECT OF NARINGIN [J].
BAILEY, DG ;
ARNOLD, JMO ;
MUNOZ, C ;
SPENCE, JD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (06) :637-642
[4]   Effect of grapefruit juice on digoxin pharmacokinetics in humans [J].
Becquemont, L ;
Verstuyft, C ;
Kerb, R ;
Brinkmann, U ;
Lebot, M ;
Jaillon, P ;
Funck-Brentano, C .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (04) :311-316
[5]   Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2) [J].
Berger, V ;
Gabriel, AF ;
Sergent, T ;
Trouet, A ;
Larondelle, Y ;
Schneider, YJ .
TOXICOLOGY LETTERS, 2003, 140 :465-476
[6]   A family of drug transporters: The multidrug resistance-associated proteins [J].
Borst, P ;
Evers, R ;
Kool, M ;
Wijnholds, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1295-1302
[7]   Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers [J].
Brand, Walter ;
van der Wel, Petronella A. I. ;
Rein, Maarit J. ;
Barron, Denis ;
Williamson, Gary ;
van Bladeren, Peter J. ;
Rietjens, Ivonne M. C. M. .
DRUG METABOLISM AND DISPOSITION, 2008, 36 (09) :1794-1802
[8]   Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients [J].
Brand, Walter ;
Schutte, Maaike E. ;
Williamson, Gary ;
van Zanden, Jelmer J. ;
Cnubben, Nicole H. P. ;
Groten, John P. ;
van Bladeren, Peter J. ;
Rietjens, Ivonne M. C. M. .
BIOMEDICINE & PHARMACOTHERAPY, 2006, 60 (09) :508-519
[9]   Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein [J].
Castro, AF ;
Altenberg, GA .
BIOCHEMICAL PHARMACOLOGY, 1997, 53 (01) :89-93
[10]   Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats [J].
Choi, JS ;
Han, HK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 305 (1-2) :122-128